Johnson & Johnson Innovation Leads Prazer Therapeutics’s Series B Round
08 Apr 2025
US$ 20.00
Johnson & Johnson Innovation - JJDC Inc (JJDC) has led the 29 bn won (US$20 m) series B financing round of Prazer...
Related Publications
Subscribers’ Weekly for the week ending 3 Apri 2026...
Listen to Subscribers' Weekly 03 Apr 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.